Search

Your search keyword '"Krishnamurthy, Balasubramanian"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Krishnamurthy, Balasubramanian" Remove constraint Author: "Krishnamurthy, Balasubramanian"
226 results on '"Krishnamurthy, Balasubramanian"'

Search Results

3. TIGIT acts as an immune checkpoint upon inhibition of PD1 signaling in autoimmune diabetes

7. Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes

8. Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis

9. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes

12. Extraislet expression of islet antigen boosts T cell exhaustion to partially prevent autoimmune diabetes.

14. Extra-islet expression of islet antigen boosts T-cell exhaustion to prevent autoimmune diabetes

15. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

16. Diabetes IN hospital – Glucose and Outcomes in the COVID ‐19 pandemic ( DINGO COVID ‐19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations

18. Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse

19. Case Report: Hypoglycemia Due to a Novel Activating Glucokinase Variant in an Adult – a Molecular Approach

21. Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by aJAK1/JAK2inhibitor

22. Diabetes IN hospital – Glucose and Outcomes in the COVID‐19 pandemic (DINGO COVID‐19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations.

24. Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer–Restricted CD4+ T Cells Infiltrate Islets in Type 1 Diabetes

25. Study on Aluminium Contamination in Mettur Soil and its Subsequent Uptake by Medicinal Plants

26. Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data

29. Reducing adverse events associated with the glucagon stimulation test for the assessment of growth hormone deficiency in adults with a high prevalence of pituitary hormone deficiencies

31. Erratum: Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

32. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP

34. Cross-Talk Between Interferon-Gamma and IL-2 Signaling Regulates Antigen-Specific CD8 + T-Cell Number

35. The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice

39. Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose to Assess Glycemia in Gestational Diabetes

42. SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy

43. OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combination Checkpoint Inhibitors

46. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study

47. 1037-P: Glucose Control following Missed and Late Meal Boluses with a Medtronic Enhanced-Hybrid Closed-Loop (E-HCL) System

48. Harnessing CD8+ T‐cell exhaustion to treat type 1 diabetes.

49. Loss of BIM increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice

Catalog

Books, media, physical & digital resources